Companies / Orthofix
1 issue
Six companies already have systems. The evidence is promising but unfinished, the wound indication isn't on the label, and scope of practice may decide who gets to use it. Plus HyperFlex walks into the lion's den, and every AOFAS 2026 industry lab in one place.
